GB-18

N/A

Report date: 2026/04/30 20:00:20

Base Information

Drug NameGB-18
Drug Alias NameGB18GB-18
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionGrowth/differentiation factor 15 modulators
TargetsGrowth/differentiation factor 15
Therapy Area/IndicationsCachexiaBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShandong Kexing Bio-Products Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesShandong Kexing Bio-Products Co LtdShenzhen Kexing Biological Engineering Co LtdShenzhen Kexing Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsCachexiaBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A